Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant
Clinical trial NCT05820763 · WITHDRAWN
Trial details
- NCT number
- NCT05820763
- Sponsor
- Washington University School of Medicine
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-05
- Primary completion
- 2027-01-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.